Page 29 - CW E-Magazine (Oct-Nov-2023)
P. 29

Sustainability Practices



           Sustainability efforts in the Indian pharmaceutical

           companies



               ustainability  has  gained  signifi-
               cant traction across many indus-
          Stry sectors worldwide in the past
           several  years. Almost every company
           in the world is making efforts to make
           their operations sustainable so as to re-
           duce their negative impact on nature.

              In short, sustainability may be de-
           fined  as  the  capacity  to  maintain  or
           support the availability  of desirable
           natural  materials  continuously  over  a  across the  world.  It  is      Table
           long period of time. It means meeting  the world’s third larg-  Top 20 Indian pharmaceutical companies by sales
           the  needs of our generation  without  est by volume  and 13            in 2022-23
                                                               th
           compromising the ability of future gen-  largest by value glob-                          [Rs. Crore]
           erations to meet their own needs. Sus-  ally.  The  major  seg-
           tainability also covers social and eco-  ments  of the  domestic   Rank Company              Sales
           nomic resources along with the natural  pharmaceutical  industry   1 Sun Pharmaceutical Industries  43,279
           resources. It is not only environmental  include  generic drugs,   2 Divi’s Laboratories     24,617
           conservation,  but also embeds social  over-the-counter  (OTC)
           equity  and economic  development.  medicines,  bulk drugs,   3 Dr. Reddy’s Laboratories     24,588
           Sustainability is considered a part of in-  vaccines,  biosimi-  4 Cipla                     22,473
           tergenerational ethics and ensures long  lars and biologics,  and
           term viability of a community. In busi-  contract  research  and   5 Emcure Pharmaceuticals  18,987
           ness and policy contexts, sustainability  manufacturing (CRAM)   6 Biocon                    17,631
           seeks to prevent depletion of natural or  services. Pharmaceuti-  7 Torrent Pharmaceuticals  16,878
           physical resources, so that they will re-  cal companies  in India
           main available for the long term.  are the largest provid-  8 Lupin                          16,249
                                             ers of generic medicines   9 Zydus Lifesciences            15,683
              Sustainability covers a wide range  by volume, with a 20%
           of actions with respect to operations of  share of the global mar-  10 Aurobindo Pharma      15,168
           an organization or company – starting  ket. Medicines and other   11 Intas Pharmaceuticals   14,657
           from simple conservation to modifying  pharmaceutical products   12 Glenmark Pharma          14,146
           chemical reactions used.          are  exported  to  over
                                             200 countries  from In-  13 Mankind Pharma                 13,634
              Indian  pharmaceutical  companies  dia. Skilled  workforce,   14 Abbott India             13,123
           have been taking efforts to implement  cost  competitiveness,
           sustainability measures at various lev-  strong R&D capabili-  15 Alkem Laboratories         12,612
           els in their operations. This article re-  ties,  as well  as positive   16 Alembic Pharmaceuticals  12,101
           views these efforts by selected pharma-  government support are
           ceutical companies in India.      important  strengths of   17 Piramal Enterprises           11,590
                                             the Indian pharmaceuti-  18 Laurus Labs                    11,079
           Indian pharmaceutical industry    cal industry. The Indian   19 Pfizer India                 10,568
              The Indian pharmaceutical industry  pharmaceutical  industry
           supplies a wide range of pharmaceuti-  is a key sector of the In-  20 GlaxoSmithKline Pharmaceuti-  10,057
           cals – APIs as well as formulations –  dian economy and plays   cals


           Chemical Weekly  October / November 2023                                                         25
   24   25   26   27   28   29   30   31   32   33   34